An avian influenza H7 DNA priming vaccine is safe and immunogenic in a randomized phase I clinical trial
Avian influenza: A vaccine for a deadly emergent strain A vaccine candidate to treat a deadly subtype of avian influenza was shown to induce protective antibodies in initial clinical trials. As of March 2017, avian influenza strain A/H7N9 has killed 497 people since 2013, with 1349 confirmed cases....
Guardado en:
Autores principales: | Adam D. DeZure, Emily E. Coates, Zonghui Hu, Galina V. Yamshchikov, Kathryn L. Zephir, Mary E. Enama, Sarah H. Plummer, Ingelise J. Gordon, Florence Kaltovich, Sarah Andrews, Adrian McDermott, Michelle C. Crank, Richard A Koup, Richard M. Schwartz, Robert T. Bailer, Xiangjie Sun, John R. Mascola, Terrence M. Tumpey, Barney S. Graham, Julie E. Ledgerwood |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e2d2da024d7c4739ac5a7e10fb271246 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
A comprehensive influenza reporter virus panel for high-throughput deep profiling of neutralizing antibodies
por: Adrian Creanga, et al.
Publicado: (2021) -
Glycan repositioning of influenza hemagglutinin stem facilitates the elicitation of protective cross-group antibody responses
por: Seyhan Boyoglu-Barnum, et al.
Publicado: (2020) -
Illusory sound texture reveals multi-second statistical completion in auditory scene analysis
por: Richard McWalter, et al.
Publicado: (2019) -
Design of Nanoparticulate Group 2 Influenza Virus Hemagglutinin Stem Antigens That Activate Unmutated Ancestor B Cell Receptors of Broadly Neutralizing Antibody Lineages
por: Kizzmekia S. Corbett, et al.
Publicado: (2019) -
The role of the NLRP3 inflammasome in gout
por: Sarah R Kingsbury, et al.
Publicado: (2011)